Australia markets closed

Heron Therapeutics, Inc. (HRTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.87000.0000 (0.00%)
At close: 04:00PM EST
2.8000 -0.07 (-2.44%)
After hours: 08:00PM EST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
122,839
107,672
86,346
88,638
Cost of revenue
67,847
54,874
46,021
36,189
Gross profit
54,992
52,798
40,325
52,449
Operating expenses
Research development
56,004
107,506
130,821
174,533
Selling general and administrative
119,738
119,950
127,332
106,079
Total operating expenses
175,742
227,456
258,153
280,612
Operating income or loss
-120,750
-174,658
-217,828
-228,163
Interest expense
-
2,474
2,410
1,901
Total other income/expenses net
1,882
-6,530
-878
-847
Income before tax
-119,704
-182,024
-220,683
-227,278
Income from continuing operations
-119,704
-182,024
-220,683
-227,278
Net income
-119,704
-182,024
-220,683
-227,278
Net income available to common shareholders
-119,704
-182,024
-220,683
-227,278
Basic EPS
-0.88
-1.67
-2.24
-2.50
Diluted EPS
-0.88
-1.67
-2.24
-2.50
Basic average shares
130,094
108,876
98,471
90,774
Diluted average shares
130,094
108,876
98,471
90,774